Latest News about Biotech
Recent news which mentions Biotech
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
Today 8:47 EST
From Benzinga
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
November 07, 2024
From Benzinga
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
November 07, 2024
From Benzinga
HIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts Boost Price Target On Raised Outlook
November 07, 2024
From Benzinga
Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware
November 07, 2024
From Benzinga
From Benzinga
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
November 06, 2024
From Benzinga
From Benzinga
Ozempic/Wegovy Maker Maintains Q3 Sales Growth On Booming Demand
November 06, 2024
From Benzinga
EasySmile Implant Studio's Launches New Website!
November 05, 2024
From PRLog
Exact Sciences Stock Plummets After Worse-Than-Expected Q3 Results, FY24 Guidance Below Estimates
November 05, 2024
From Benzinga
Gene Therapy Developer Beam Therapeutics Reports One Patient Death In Early-Stage Sickle Cell Disease Trial
November 05, 2024
From Benzinga
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
November 05, 2024
From Benzinga
CAMP4 Analyst Highlights Rare Disease Platform Potential
November 05, 2024
From Benzinga
Why Is AstraZeneca Stock Sinking On Tuesday?
November 05, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|